Pregled bibliografske jedinice broj: 851646
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation // Biology of blood and marrow transplantation, 21 (2015), 8; 1431-1436 doi:10.1016/j.bbmt.2015.04.003 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 851646 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation
Autori
Perić, Zinaida ; Cahu, Xavier ; Malard, Florent ; Brissot, Eolia ; Chevallier, Patrice ; Guillaume, Thierry ; Gregoire, Marc ; Gaugler, Beatrice ; Mohty, Mohamad
Izvornik
Biology of blood and marrow transplantation (1083-8791) 21
(2015), 8;
1431-1436
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Allogeneic transplantation ; GVHD ; Outcome ; Plasmacytoid dendritic cell
Sažetak
The rapidly increasing use of allogeneic stem cell transplantation (allo-SCT) emphasizes the need for identifying variables predictive of its outcome. Plasmacytoid dendritic cells (pDCs) play a major role in establishing immune competence and in several autoimmune diseases. Thus, we investigated whether pDCs might influence the outcome of patients after allo-SCT in 79 consecutive patients who underwent this procedure. pDCs were identified in the blood of patients at day 100 after allo-SCT by staining peripheral blood mononuclear cells for surface markers and intracellular cytokines and analyzing them on a flow cytometer. We found the pDC level at day 100 was not influenced by patient or graft characteristics, and only the absence of previous grades II to IV acute graft-versus-host disease was significantly associated with higher levels of blood pDCs after allo-SCT (OR, .67 ; 95% CI, .54 to .83 ; P = .0004). Using the median value of pDCs at day 100 to divide the patients into 2 distinct groups, we observed that a low pDC level was correlated with a worse overall survival (55% versus 86%, P = .007). In a multivariate analysis, only low pDC level (OR, 3.41 ; 95% CI, 1.19 to 9.79 ; P = .02) and older patient age (OR, 5.16 ; 95% CI, 1.15 to 23.14 ; P = .03) were significantly predictive of increased risk of death. We conclude that monitoring of pDC may be useful for patient management and may have a significant impact on the probability of a favorable outcome of allo-SCT.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE